Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial

[1] Diener-West M(2001)The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18 Arch Ophthalmol 119 969-982

[2] Earle JD(2003)Very long-term prognosis of patients with malignant uveal melanoma Invest Ophthalmol Vis Sci 44 4651-4659

[3] Fine SL(2003)Phase II evaluation of temozolomide in metastatic choroidal melanoma Melanoma Res 13 303-306

[4] Hawkins BS(2005)Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma Melanoma Res 15 205-207

[5] Moy CS(2003)Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma Eur J Cancer 39 1115-1120

[6] Reynolds SM(2013)Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM) J Clin Oncol Suppl 15 CRA9003-48

[7] Schachat AP(2012)Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy Cancer Immunol Immunother 61 41-1788

[8] Straatsma BR(2013)Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O) Acta Oncol 52 1786-1197

[9] Kujala E(2009)Surgical management of liver metastases from uveal melanoma: 16 years’ experience at the institut curie Eur J Surg Oncol 35 1192-e44

[10] Makitie T(2012)Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study J Clin Oncol 30 Abstract 8532-165

[1] Diener-West M(2001)The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18 Arch Ophthalmol 119 969-982

[2] Earle JD(2003)Very long-term prognosis of patients with malignant uveal melanoma Invest Ophthalmol Vis Sci 44 4651-4659

[3] Fine SL(2003)Phase II evaluation of temozolomide in metastatic choroidal melanoma Melanoma Res 13 303-306

[4] Hawkins BS(2005)Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma Melanoma Res 15 205-207

[5] Moy CS(2003)Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma Eur J Cancer 39 1115-1120

[6] Reynolds SM(2013)Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM) J Clin Oncol Suppl 15 CRA9003-48

[7] Schachat AP(2012)Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy Cancer Immunol Immunother 61 41-1788

[8] Straatsma BR(2013)Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O) Acta Oncol 52 1786-1197

[9] Kujala E(2009)Surgical management of liver metastases from uveal melanoma: 16 years’ experience at the institut curie Eur J Surg Oncol 35 1192-e44

[10] Makitie T(2012)Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study J Clin Oncol 30 Abstract 8532-165